Future Outlook of the Oral Solid Dosage Contract Manufacturing Market: Growth, Trends, and Emerging Opportunities Explored
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the oral solid dosage contract manufacturing market size evolved in recent years?
The market size for oral solid dosage contract manufacturing has seen significant growth in the recent past. The market is predicted to expand from $39.39 billion in 2024 to $42.51 billion by 2025 with a compound annual growth rate (CAGR) of 7.9%. This growth during the historical period can be credited to an increasing worldwide population, high incidence of chronic illnesses, and an enhanced focus on research and development.
What are the predictions for the oral solid dosage contract manufacturing market size in the coming years?
In the coming years, the market size for oral solid dosage contract manufacturing is anticipated to witness robust growth. The market is projected to expand to $56.89 billion by 2029, at a compound annual growth rate (CAGR) of 7.6%. This growth over the forecast period is primarily due to the escalating trend of outsourcing by pharmaceutical enterprises, improvements in drug delivery technology, and a rise in drug development activities. Upcoming trends for the forecast period encompass technological advancements in drug delivery, the incorporation of 3D printing, and developments in controlled-release technologies.
Get your oral solid dosage contract manufacturing market report here!
What key factors are fueling the growth of the oral solid dosage contract manufacturing market?
The uptick in demand for generic medications is projected to fuel the expansion of the oral solid dosage contract manufacturing market. These generic drugs, which are essentially equivalent to branded drugs in terms of dosage, strength, safety, performance, quality, and functionality, are becoming increasingly popular due to factors such as patent expiry, cost-saving initiatives, regulatory incentives, and broader access to healthcare services. The contract manufacturing of oral solid dosages plays a vital role in the production and distribution of these generic medications, utilising the strengths of contract manufacturers to improve operational efficiency, decrease costs, guarantee high-quality production, and quickly and effectively bring products to market. To illustrate, the US-based federal agency, the Food and Drug Administration, reported in 2022 that approximately 91% of all prescriptions in the US were supplied by generic drugs, with over 32,000 generic medications gaining FDA approval. Resultantly, this increased demand for generic drugs propels the growth of the oral solid dosage contract manufacturing market.
How is the global oral solid dosage contract manufacturing market divided into key segments?
The oral solid dosage contract manufacturing market covered in this report is segmented –
1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies
Subsegments:
1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets (Enteric, Film Coated), Sustained Or Controlled Release Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules
3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders
4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules
5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp
Who are the key firms paving the way for growth in the oral solid dosage contract manufacturing market?
Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation
What are the key trends shaping the future of the oral solid dosage contract manufacturing market?
Key players in the market for oral solid dosage contract manufacturing are striving to remain competitive by introducing innovative solutions including continuous manufacturing lines. These refer to production facilities or systems that use ongoing manufacturing procedures to create pharmaceuticals or other items. For instance, WuXi STA, a pharmaceutical firm based in China, initiated its debut continuous manufacturing line for oral solid pharmaceutical products in January 2023. This state-of-the-art facility represents a crucial progress in the production of pharmaceuticals, utilizing continuous manufacturing concepts to improve efficiency, quality and flexible manufacturing processes. This adaptability improves production schedules and cuts down on downtime, ultimately speeding up the distribution of essential drugs to patients.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16137
What regions are contributing significantly to the growth of the oral solid dosage contract manufacturing market?
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Electronic Contract Manufacturing and Design Services Global Market Report 2024
Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2024
Food Contract Manufacturing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/food-contract-manufacturing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
